CareLit Fachartikel

CFTR mRNA Based Gene Therapy for cystic fibrosis (CF)

A Yamamoto, M Illenyi, M Kormann, J Rosenecker, C Rudolph · Pneumologie · 2008 · Heft 01

Dokument
1136306
CareLit-ID
Jahr
2008
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
A Yamamoto, M Illenyi, M Kormann, J Rosenecker, C Rudolph
Ausgabe
Heft 01 / 2008
Seiten
–
Erschienen: 2008-01-07 00:00:00
ISSN
0934-8387

Zusammenfassung

Cystic fibrosis (CF) is a lethal autosomal recessive genetic disease which affects over 70, 000 people in the world. The responsible gene for CF was identified in 1989, so called CFTR (cystic fibrosis transmembrane conductance -regulator), and CF is caused by over 1300 mutations in CFTR. Among these mutations, deletion phenylalanine 508 (dF508) causes more than 90% cases of CF. Main pathological features are thick and dehydrate airway mucus, high sweat Cl- etc, and major site of CF pathology is lung, accompanying infection by S. aureus and P.aureginosa. Life expectancy is around 30 years. CFTR is localized in ch…

Schlagworte

Cystic Fibrosis Transmembrane Conductance Regulator Amino Acids Lead Pneumologie